Skip to main content
Michael P. Teske
( out of 354 reviews )

Michael P. Teske, MD

Languages spoken: English

Clinical Locations

  • Michael P. Teske is the Director of Vitreoretinal Diseases and Surgery. Dr. Teske specializes in medical and surgical diseases of the retina and vitreous. His primary surgical interests include retinal detachment, proliferative vitreoretinopathy, diabetic retinopathy, retinopathy of prematurity, epiretinal membranes, macular holes and posterior segment trauma.

    Board Certification

    American Board of Ophthalmology
    National Board of Medical Examiners

    Patient Rating

    4.9 /5
    ( out of 354 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    August 24, 2023
    MORAN EYE CENTER

    Dr Teske wasn't available. His replacement is very good.

    August 24, 2023
    CLINICAL NEUROSCIENCES CENTER

    She listened. She explained things. After I thought we were done, she came back a couple of times which indicated to me that she was interested in providing the best possible care.

    August 24, 2023
    MORAN EYE CENTER

    Dr. Teske has been one of my medical professionals for surgery and other care for several years. He was not present for my last appointment, but I received care from Dr. Fuller and other staff. Dr. Fuller and others were excellent.

    August 24, 2023
    MORAN EYE CENTER

    We did not see Dr Teske, but Dr Fuller was very professional and was informative in my car. We feel confidence in the drs and staff.

    August 21, 2023
    MORAN EYE CENTER

    Very professional and caring and competent.

    August 21, 2023
    MORAN EYE CENTER

    Helpful, authoritative and caring.

    August 20, 2023
    MORAN EYE CENTER

    Dr Tesky gives me prompt, excellent, care to preserve my sight as I age and need to continue living and driving myself to appointments and social outings without the need of a driver.

    August 17, 2023
    MORAN EYE CENTER

    Great doctor, cheerful disposition, very informative, and excellent surgeon.

    August 13, 2023
    MORAN EYE CENTER

    Excellent

  • Michael P. Teske is the Director of Vitreoretinal Diseases and Surgery. Dr. Teske specializes in medical and surgical diseases of the retina and vitreous. His primary surgical interests include retinal detachment, proliferative vitreoretinopathy, diabetic retinopathy, retinopathy of prematurity, epiretinal membranes, macular holes and posterior segment trauma.

    Board Certification and Academic Information

    Academic Departments Ophthalmology & Visual Sciences -Primary
    Board Certification
    American Board of Ophthalmology
    National Board of Medical Examiners

    Education history

    Fellowship Retina/Vitreous - Wayne State University, Kresge Eye Institute Fellow
    Ophthalmology - University of Utah School of Medicine Resident
    Internship Internal Medicine - University of Utah School of Medicine Intern
    Medicine - University of California - Los Angeles M.D.
    Undergraduate University of Notre Dame B.S.

    Selected Publications

    Journal Article

    1. Birch DG, Bernstein PS, Iannacone A, Pennesi ME, Lam BL, Heckenlively J, Csaky K, Hartnett ME, Winthrop KL, Jayasundera T, Hughbanks-Wheaton DK, Warner J, Yang P, Fish GE, Teske MP, Sklaver NK, Erker L, Chegarnov E, Smith T, Wahle A, VanVeldhuisen PC, McCormack J, Lindblad R, Bramer S, Rose S, Zilliox P, Francis PJ, Weleber RG (08/01/2018). Effect of Oral Valproic Acid vs. Placdbo for Vision Loss in Paients With Autosomal Dominant Retinitis Pigmentosa: A Randomized Phase 2 Multicenter Placebo-Controlled Clinical Trial. JAMA Ophthalmol, 136(8), 849-856.
    2. Birch DG, Bernstein PS, Iannacone A, Pennesi ME, Lam BL, Heckenlively J, Csaky K, Hartnett ME, Winthrop KL, Jayasundera T, Hughbanks-Wheaton DK, Warner J, Yang P, Fish GE, Teske MP, Sklaver NL, Erker L, Chegarnov E, Smith T, Wahle A, VanVeldhuisen PC, McCormack J, Lindblad R, Bramer S, Rose S, Zilliox P, Francis PJ, Weleber RG (2018). Effect of Oral Valproic Acid vs Placebo for Vision Loss in Patients With Autosomal Dominant Retinitis Pigmentosa: A Randomized Phase 2 Multicenter Placebo-Controlled Clinical Trial. JAMA Ophthalmol, 136(8), 849-856. (Read full article)
    3. Bell JE, Shulman JP, Swan RJ, Teske MP, Bernstein PS (2017). Intravitreal Versus Subretinal Tissue Plasminogen Activator Injection for Submacular Hemorrhage. Ophthalmic Surg Lasers Imaging Retina, 48(1), 26-32. (Read full article)
  • News & Podcasts